COVID-19 Study

COVID-19 is a contagious respiratory illness that can range from mild symptoms, like a sore throat, fatigue, cough or fever, to severe complications, especially in older adults and those with underlying health conditions. While many people recover quickly, others may experience lasting effects such as shortness of breath, brain fog or fatigue. COVID-19 continues to impact individuals, families, and communities worldwide. For some, it can interrupt daily life, limit independence, and cause emotional or physical distress, especially when symptoms linger, or complications arise. 

Current treatments for COVID-19 focus on symptom relief, antiviral medications, and supportive care, especially for those at higher risk. While vaccines have significantly reduced severe illness and death, not everyone responds the same, and the virus continues to evolve. Clinical research plays a vital role in developing better treatments, including antiviral therapies and targeted prevention options for vulnerable populations.

This study is exploring whether a potential new antiviral treatment can target the virus early to reduce symptoms and prevent progression to severe illness in people who are at higher risk.

You will be assessed by a member of our clinical team to confirm eligibility. If you qualify, you will be assigned to receive treatment.

Over a period of approximately one month, you will attend several clinic visits and check-ins. These will include health assessments, symptom monitoring, and follow-up tests.
Your safety and wellbeing will be carefully monitored throughout the study by an experienced medical team.

Why join this clinical research study?

• By participating, you will contribute to research and receive study-related care at no cost
• Contribute to research focused on early intervention for high-risk individuals
• Receive personalised care and regular health checks

Your privacy is important. All personal information will be kept strictly confidential.

Register your interest today.